Acetaminophen Special Populations Toxicity Data Lacking, NDAC Says

There are insufficient data on special populations or disease states to warrant acetaminophen label changes to warn such individuals they may be at increased risk for hepatotoxicity, FDA's Nonprescription Drugs Advisory Committee concluded Sept. 19